Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Endra Life Sciences Inc. > Profile

Endra Life Sciences Inc. (NDRA)

Market is closed

Sector: National Commercial Banks

Hedge Fund Popularity

Display

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on March 18, 2025, 4:33 pm based on SEC 13F filings Last update: March 18, 2025, 4:33 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Brevan Howard Alan Howard	0	$0		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Ubs Other	$0.00	0	$0.00	146,012	2024-08-27	Filing
Ubs Large Shareholder	$0.55	3,715	$2,051.79	146,012	2024-08-27	Filing
Thornton Officer	$1.65	15,000	$24,750.00	34,139	2023-05-18	Filing
Digiandomenico Director	$1.20	83,333	$99,999.60	102,434	2023-05-02	Filing
Thornton Officer	$3.40	1,500	$5,100.00	19,139	2022-12-09	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Basenese Director	$1.85	5,000	$9,250.00	49,068	2021-08-26	Filing
Basenese Director	$1.83	45,000	$82,350.00	54,068	2021-08-25	Filing
Thornton Officer	$2.53	15,000	$37,950.00	259,960	2021-04-07	Filing
Thornton Officer	$2.37	18,750	$44,437.50	274,960	2021-03-29	Filing
Maloberti Officer	$1.10	13,696	$15,065.60	1,580	2021-01-13	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Tower Research Capital Llc (trc)	1,130	$4,633	0%
2.	Bank Of America Corp	4	$16	0%
3.	Morgan Stanley	0	$0	0%
4.	Proequities, Inc.	0	$0	0%
5.	Ubs Group Ag	0	$0	0%

News See All

Click here to See All News